Prostaglandin H2

Prostaglandin H2 is a type of prostaglandin and a precursor for many other biologically significant molecules. It is synthesized from arachidonic acid in a reaction catalyzed by a cyclooxygenase enzyme.[1] The conversion from Arachidonic acid to Prostaglandin H2 is a two step process. First, COX-1 catalyzes the addition of two free oxygens to form the 1,2-Dioxane bridge and a peroxide functional group to form Prostaglandin G2.[2] Second, COX-2 reduces the peroxide functional group to a Secondary alcohol, forming Prostaglandin H2. Other peroxidases like Hydroquinone have been observed to reduce PGG2 to PGH2.[3] PGH2 is unstable at room temperature, with a half life of 90-100 seconds,[4] so it is often converted into a different prostaglandin.

Eicosanoid synthesis - prostaglandin H2 near center
Prostaglandin H2
Names
Other names
PGH2, Endoperoxide H2, Prostaglandin R2
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
MeSH Prostaglandin+H2
UNII
Properties
C20H32O5
Molar mass 352.465 g/mol
Density 1.129 ± 0.06 g/mL
Boiling point 490 ± 40.0 °C
0.034 g/L
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YN ?)
Infobox references

It is acted upon by:

It rearranges non-enzymatically to:

Use of prostaglandin H2:

  • regulating the constriction and dilation of blood vessels
  • stimulating platelet aggregation
    • binds to Thromboxane receptor on platelets' cell membranes to trigger platelet migration and adhesion to other platelets.[5]

Effects of Aspirin on prostaglandin H2:

  • Aspirin has been hypothesized to block the conversion of arachidonic acid to prostaglandin
Figure 1: Synthetic pathways from PGH2 (the parent compound) to prostaglandins, prostacyclin and thromboxanes

References

  1. van der Donk WA, Tsai AL, Kulmacz RJ (December 2002). "The cyclooxygenase reaction mechanism". Biochemistry. 41 (52): 15451–8. doi:10.1021/bi026938h. PMID 12501173.
  2. Salomon RG, Miller DB, Zagorski MG, Coughlin DJ (October 1984). "Prostaglandin endoperoxides. 14. Solvent-induced fragmentation of prostaglandin endoperoxides. New aldehyde products from PGH2 and a novel intramolecular 1,2-hydride shift during endoperoxide fragmentation in aqueous solution". Journal of the American Chemical Society. 106 (20): 6049–6060. doi:10.1021/ja00332a049. ISSN 0002-7863.
  3. Hla T, Neilson K (August 1992). "Human cyclooxygenase-2 cDNA". Proceedings of the National Academy of Sciences of the United States of America. 89 (16): 7384–8. Bibcode:1992PNAS...89.7384H. doi:10.1073/pnas.89.16.7384. PMC 49714. PMID 1380156.
  4. "Human Metabolome Database: Showing metabocard for Prostaglandin H2 (HMDB0001381)". www.hmdb.ca. Retrieved 2019-11-19.
  5. Woodward DF, Jones RL, Narumiya S (September 2011). "International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress". Pharmacological Reviews. 63 (3): 471–538. doi:10.1124/pr.110.003517. PMID 21752876.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.